Trans-NIH Mouse Initiative
*Funding Opportunitites


RFA on Immunological Phenotyping of Mouse Mutants

This is an RFA to develop novel, high throughput technologies for self-tolerance, and autoimmune injury in mice. Because immunological disorders are not apparent upon inspection and because many immune-mediated disorders, including autoimmune diseases, evolve over time, new technologies are required to screen large numbers of mutant mice. These may be entirely new or may be adapted from existing techniques. In all cases, these technologies should be rapid, accurate, relatively cost efficient and should minimize the necessity to sacrifice valuable mutant mice.

Additional information about this RFA can be found at